Clinical trials
Phase 4 Chlamydia Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 5 |
| University of Washington | 2 |
| Ain Shams Maternity Hospital | 1 |
| Bangrak STIs Center | 1 |
| Brigham and Women's Hospital | 1 |
| Chinese University of Hong Kong | 1 |
| Johns Hopkins University | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| National Taiwan University Hospital | 1 |
| Westat | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chlamydia Infections | 16 |
| Gonorrhea | 9 |
| Sexually Transmitted Diseases | 6 |
| Syphilis | 6 |
| Trachoma | 5 |
| Bacterial Infections | 3 |
| Eye Diseases | 2 |
| Infections | 2 |
| Communicable Diseases | 1 |
| Diarrhea | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.